Pricing Log in Create free account
Saturday 17 October 2026 Export TECH’s income statement to Excel — free account

Bio-Techne Corp

TECH Healthcare Biotechnology

Bio-Techne Corp’s revenue for fiscal 2026 (year ended June 2026) was $1.2 billion, roughly unchanged from fiscal 2025. In the quarter to June 2026, revenue grew 1.33%, EPS grew 418.2%, free cash flow fell 6.83% and total debt fell 42.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years.

72.54 0.02 +0.03%
Market cap
$11.4B
P/E
62.0×
Fwd P/E
37.6×
Dividend yield
0.44%
F-score
9/9
Altman Z
15.50
Beneish M
−2.52
Dividend safety
78/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Bio-Techne Corp (TECH) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Bio-Techne Corp (TECH) trades at a P/E ratio of 62.0×. Over the past ten years it has ranged from 28.5× (January 2015) to 148× (September 2021); the current reading is higher than 62% of that period. That is above the Biotechnology industry median of 8.5× and above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2026 60.4× (46.01%)
FY2025 112× 65.56%
FY2024 67.6× 50.62%
FY2023 44.9× (10.20%)
FY2022 49.9× (59.73%)
FY2021 124× 181.83%
FY2020 44.0× (46.79%)
FY2019 82.7× 86.38%
FY2018 44.4× (26.36%)
FY2017 60.3× 50.19%

Quarterly newest first

Period P/E ratio Change
Jun 2026 60.4× (17.96%)
Mar 2026 73.6× (34.92%)
Dec 2025 113× 1.65%
Sep 2025 111× (0.53%)
42 more quarters

Against its own ten years

Low 28.5× High 148×
Ten-year median 54.3×
Current reading's percentile 59

P/E ratio against peers

Company P/E ratio
IBRX ImmunityBio, Inc. compare n/m
MDGL Madrigal Pharmaceuticals, Inc. compare n/m
SMMT Summit Therapeutics PLC compare n/m
BBIO BridgeBio Pharma, Inc. compare n/m
PCVX Vaxcyte, Inc. compare n/m
KRYS Krystal Biotech, Inc. compare 38.3×
TECH Bio-Techne Corp 62.0×
BMRN BioMarin Pharmaceutical Inc. compare 144×
CORT Corcept Therapeutics Incorporated compare 212×
Biotechnology industry median 8.5×
Healthcare sector median 23.0×
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on TECH